CVR: 25332520
Previous names: LICA PHARMACEUTICALS A/S
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med forskning indenfor medicinalbranchen og hermed beslægtet virksomhed med henblik på kommerciel udnyttelse og salg af forskningsresultaterne.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | 451 t. | 24.5 mio. | 24.2 mio. | 1 | |
| 2024 | - | 1.4 mio. | 24.2 mio. | 23.8 mio. | 1 | |
| 2023 | - | 1.7 mio. | 22.4 mio. | 22.4 mio. | 1 | |
| 2022 | - | -1.5 mio. | 20.7 mio. | 20.6 mio. | 1 | |
| 2021 | - | 2.6 mio. | 22.3 mio. | 22.2 mio. | 1 | |
| 2020 | - | 844 t. | 19.7 mio. | 19.6 mio. | 0 | |
| 2019 | - | 2.8 mio. | 18.9 mio. | 18.8 mio. | - | |
| 2018 | - | 5.6 mio. | 18.5 mio. | 18.4 mio. | - | |
| 2017 | - | 812 t. | 12.9 mio. | 12.8 mio. | - | |
| 2016 | - | 328 t. | 12.1 mio. | 12 mio. | - | |
| 2015 | - | -2.3 mio. | 11.7 mio. | 11.7 mio. | - | |
| 2014 | - | 3.9 mio. | 13.9 mio. | 13.9 mio. | - | |
| 2013 | - | 783 t. | 10.1 mio. | 10 mio. | - | |
| 2012 | 468 t. | 953 t. | 9.3 mio. | 9.3 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Contact info changed: new phone: 40107500, new email: [email protected] (June 20, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 19, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 19, 2026).
As of June 19, 2026, Arsalan Kharazmi is registered as an owner of LICA PHARMACEUTICALS ApS with an ownership share of 100%.
Contact info changed: new phone: 40107500, new email: [email protected] (June 18, 2026).
As of June 18, 2026, Karin Birgitte Sonne Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of June 18, 2026, Leila Eileen Gedsø-Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of June 18, 2026, Arsalan Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
On June 18, 2026, the company changed its name from LICA PHARMACEUTICALS A/S to LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2025. Gross profit came to DKK 359,449, and the net result was DKK 450,710.
LICA PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK 210,297, and the net result was DKK 1,406,816.
LICA PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 234,223, and the net result was DKK 1,731,068.
LICA PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK 312,597, and the net result was DKK -1,524,785.
LICA PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 370,721, and the net result was DKK 2,563,807.
LICA PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK 326,213, and the net result was DKK 843,617.
As of December 31, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of December 31, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 279,654, and the net result was DKK 2,782,288.
LICA PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK 973,018, and the net result was DKK 5,572,310.
LICA PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 408,690, and the net result was DKK 812,469.
LICA PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK 737,979, and the net result was DKK 327,524.
LICA PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK 312,007, and the net result was DKK -2,255,485.
As of December 21, 2015, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of December 21, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 269,406, and the net result was DKK 3,869,932.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 341,415, and the net result was DKK 782,891.
LICA PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 468,291, and the net result was DKK 953,184.
As of September 18, 2012, JUT NR. 2180 A/S has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of May 25, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LICA PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of July 1, 2011, A/S PSE NR. 2857 has stepped down as auditor of LICA PHARMACEUTICALS ApS.
As of January 11, 2008, Mark Sonne Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Karin Birgitte Sonne Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Mark Sonne Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Leila Eileen Gedsø-Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Michael Betto Vibe Fiorini has left the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Eva Steiness has left the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Søren Brøgger Christensen has left the board of directors of LICA PHARMACEUTICALS ApS.
As of May 6, 2004, Michele Garufi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Søren Brøgger Christensen has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Per Anders Göte Samuelsson has left the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Gunnar Magnus Severus Modée Persson has left the board of directors of LICA PHARMACEUTICALS ApS.
As of April 3, 2001, Michele Garufi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 22, 2000, Gunnar Magnus Severus Modée Persson has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 22, 2000, Björn Ingemar Odlander has left the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Eva Steiness has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Björn Ingemar Odlander has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Per Anders Göte Samuelsson has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Arsalan Kharazmi is registered as adm. dir. of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Per Thor Lassen has stepped down as adm. dir. of LICA PHARMACEUTICALS ApS.
As of June 1, 2000, Per Thor Lassen has left the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, A/S PSE NR. 2857 has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Per Thor Lassen has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Michael Betto Vibe Fiorini has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Arsalan Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Per Thor Lassen is registered as adm. dir. of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS was founded on April 12, 2000.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 42666084
CVR 27701396